Coeptis Therapeutics Hldgs Inc (COEP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,828 | 2,922 | 3,366 | 7,901 | 3,685 |
| Operating Income | -2,828 | -2,922 | -3,366 | -7,901 | -3,685 |
| Interest Expense | 66 | 201 | 14 | 20 | 43 |
| Other Income | -141 | 122 | -376 | 1,571 | 525 |
| Pre-tax Income | -3,035 | -3,001 | -3,756 | -6,351 | -3,203 |
| Net Income Continuous | -3,035 | -3,001 | -3,756 | -6,351 | -3,203 |
| Net Income | $-3,035 | $-3,001 | $-3,756 | $-6,351 | $-3,203 |
| EPS Basic Total Ops | -0.08 | -0.08 | -0.76 | -4.80 | -3.00 |
| EPS Basic Continuous Ops | -0.08 | -0.08 | -0.94 | -4.77 | -2.94 |
| EPS Diluted Total Ops | -0.08 | -0.08 | -0.76 | -4.80 | -3.00 |
| EPS Diluted Continuous Ops | -0.08 | -0.08 | -0.94 | -4.77 | -2.94 |
| EPS Diluted Before Non-Recurring Items | -1.60 | -1.60 | -1.60 | N/A | N/A |
| EBITDA(a) | $-2,578 | $-2,522 | $-3,116 | $-7,651 | $-3,435 |